Understanding Behçet Disease in children and teens
Part of Eyes & vision, Genetic & congenital, Heart & circulation, Mouth & dental, Skin clinical trials.
This study looks at the health records and blood tests of children and young adults with Behçet disease to learn more about the condition. It also compares their results with healthy children to find clues that may help doctors better understand and treat Behçet disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Behçet disease using standard medical criteria.
- You are between 6 months and 70 years old.
- You or your legal guardian can agree to take part in the study.
- You do not have another medical condition that could explain your symptoms.
- If you are a healthy control, you must be under 18 and not have any inflammatory or autoimmune conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a blood thinner (rivaroxaban) to standard immune therapy is better than immune therapy alone for treating blood clots in the legs caused by Behçet's disease. It may help prevent clots from getting worse or recurring.
This study looks at how the thickness of the femoral vein wall and certain markers of inflammation relate to Behcet disease. It may help doctors better understand and monitor the condition.
This study looks at levels of a protein called EBI-3 in the blood of people with Behçet's disease. It may help doctors better understand the disease and could lead to better diagnosis or treatment.
This Phase 2 trial tests tocilizumab and tofacitinib to see if they can better control vascular (blood-vessel) Behçet’s syndrome. It may help by lowering inflammation and reducing complications from aneurysms in the aorta or peripheral arteries.
This study looks at the symptoms, lab results, and treatments for people with Behçet's disease in Assiut. It aims to improve how the disease is diagnosed and managed.
This study tests a new pill called Hemay005 for adults with Behçet's disease who have at least two mouth sores that need treatment beyond creams or rinses. It aims to see if the drug safely reduces mouth ulcers.
Hear when a new Behcet Disease and Vascular Involvement trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.